2020 annual financial data
Rigel Pharmaceuticals 2020 Revenue growth
Direct answer
Revenue growth was 83.21%.
Operating income was -28,973,000 USD and net income was -29,744,000 USD.
Operating cash flow was -52,185,000 USD.
Get free Rigel Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 108,621,000 USD
- Operating income
- -28,973,000 USD
- Net income
- -29,744,000 USD
- Operating cash flow
- -52,185,000 USD